<DOC>
	<DOCNO>NCT02060591</DOCNO>
	<brief_summary>The Investigators aim study efficacy Exparel compare Marcaine , take account pain control , narcotic consumption , narcotic-related side effect , outcome measure , patient satisfaction . Moreover , Investigators plan perform cost-benefit analysis evaluate whether use Exparel decrease analgesic consumption , duration hospital stay need physical therapy postoperatively , therefore , offset high price comparison Marcaine .</brief_summary>
	<brief_title>Comparison Two Periarticular Injection Medications Adjunctive Pain Management Following Total Knee Arthroplasty ( TKA )</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>All patient least 18 year old primary unilateral TKA osteoarthritis perform Thomas Jefferson University Hospital . American Society Anesthesiologist ( ASA ) score 4 high Hepatic disease ( contraindication acetaminophen ) Renal disease ( contraindication NSAIDs ) Any contraindication oxycodone , ketorolac , epinephrine , pregabalin , gabapentin , hydromorphone , Tramadol , morphine narcotic consider part routine postoperative pain control protocol Fibromyalgia Any contraindication intrathecal opioid injection History substance abuse last 2 year History allergy amide compound Current consumption monoaminoxidase ( MAO ) inhibitor tricyclic antidepressant ( TCA ) medication Allergy metabisulfite compound Chronic use opioid medication month prior surgery ( lead opioid tolerance and/or opioidinduced hyperalgesia ) Body weight &lt; 50 Kg , BMI &gt; 40 Kg/m2 History hypotension Patients surgery related complication first 46 week follow TKA , infection mechanical failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>